Report Detail
Global AI Cardiovascular Screening System Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4658306 |
- 16 February, 2026 |
- Global |
- 105 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global AI Cardiovascular Screening System market size was valued at US$ 585 million in 2025 and is forecast to a readjusted size of US$ 2651 million by 2032 with a CAGR of 23.9% during review period.
AI Cardiovascular Screening Systems are artificial intelligence–enabled solutions designed to support the early identification and risk stratification of cardiovascular diseases through non-invasive imaging and physiological data analysis. Unlike diagnostic systems used for definitive clinical confirmation, these systems focus on screening and triage, aiming to detect potential abnormalities at an early stage and prioritize patients for further evaluation. Typical inputs include echocardiography, vascular ultrasound, ECG, blood pressure data, and increasingly multimodal datasets. AI models automate tasks such as view recognition, automated measurements (e.g., chamber size, ejection fraction surrogates), abnormal pattern detection, and population-level risk scoring. These systems are widely applied in outpatient clinics, health check-up centers, primary care, and community screening programs, where efficiency, consistency, and scalability are critical.
From a multi-dimensional classification perspective, the market can be parameterized by screening modality (cardiac ultrasound–based, vascular ultrasound–based, ECG-based, or multimodal screening), target population (general population screening, high-risk groups such as hypertension or diabetes patients, occupational or elderly screening), AI functional scope (automated measurements, abnormality flagging, risk stratification, workflow triage), and deployment model (on-device embedded systems, hybrid edge–cloud platforms, or centralized cloud screening services). Regulatory positioning also differentiates solutions into research or wellness-oriented screening tools versus clinically validated screening systems cleared for medical use.
The value chain starts upstream with imaging device manufacturers, sensor and semiconductor suppliers, and data infrastructure providers. Midstream players include AI algorithm developers, cardiovascular software vendors, and system integrators responsible for embedding screening AI into existing ultrasound, ECG, or health IT platforms. Downstream customers consist of hospitals, outpatient cardiology clinics, primary care networks, health screening centers, and public health organizations. Partnerships with device OEMs and healthcare providers are particularly important, as screening systems must integrate smoothly into high-throughput workflows and existing information systems.
From an economic perspective, AI cardiovascular screening systems benefit from a software-heavy cost structure, with R&D, data annotation, clinical validation, and regulatory compliance representing the largest fixed costs. Once deployed at scale, incremental screening costs are relatively low, supporting favorable gross margins compared with traditional hardware-centric solutions. Market trends point toward rapid growth driven by aging populations, rising cardiovascular disease prevalence, expansion of preventive healthcare, and increasing adoption of AI-enabled point-of-care screening. Future developments are expected to include broader multimodal screening platforms, deeper integration with population health management systems, and wider use in large-scale preventive and community-based screening programs.
This report is a detailed and comprehensive analysis for global AI Cardiovascular Screening System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Cardiovascular Screening System market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Cardiovascular Screening System market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Cardiovascular Screening System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Cardiovascular Screening System market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Cardiovascular Screening System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Cardiovascular Screening System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE Healthcare, Philips, UltraSight, Us2.ai, Ultromics, Butterfly Network, Exo Imaging, Canon Medical, Mindray, Samsung Medison, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Cardiovascular Screening System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ultrasound-based Screening
ECG-based Screening
Multimodal Imaging Screening
Non-imaging Signal-based Screening
Hybrid Clinical Data Screening
Market segment by Deployment & Integration Model
On-device / Embedded AI Solutions
Hybrid Edge–Cloud AI Platforms
AI Plug-ins for Existing Ultrasound Systems
Others
Market segment by AI Functional Depth
Scan Guidance & View Recognition
Automated Measurement & Quantification
Structural & Functional Abnormality Detection
Disease Classification & Risk Stratification
Others
Market segment by Application
Medical Institutions
Great Health Scene
Market segment by players, this report covers
GE Healthcare
Philips
UltraSight
Us2.ai
Ultromics
Butterfly Network
Exo Imaging
Canon Medical
Mindray
Samsung Medison
Clarius Mobile Health
HEBIN
Demetics Medical Technology
Shukun Technology
Shenzhen Keya Medical Technology（）
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Cardiovascular Screening System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Cardiovascular Screening System, with revenue, gross margin, and global market share of AI Cardiovascular Screening System from 2021 to 2026.
Chapter 3, the AI Cardiovascular Screening System competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Cardiovascular Screening System market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Cardiovascular Screening System.
Chapter 13, to describe AI Cardiovascular Screening System research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of AI Cardiovascular Screening System by Type
- 1.3.1 Overview: Global AI Cardiovascular Screening System Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global AI Cardiovascular Screening System Consumption Value Market Share by Type in 2025
- 1.3.3 Ultrasound-based Screening
- 1.3.4 ECG-based Screening
- 1.3.5 Multimodal Imaging Screening
- 1.3.6 Non-imaging Signal-based Screening
- 1.3.7 Hybrid Clinical Data Screening
- 1.4 Classification of AI Cardiovascular Screening System by Deployment & Integration Model
- 1.4.1 Overview: Global AI Cardiovascular Screening System Market Size by Deployment & Integration Model: 2021 Versus 2025 Versus 2032
- 1.4.2 Global AI Cardiovascular Screening System Consumption Value Market Share by Deployment & Integration Model in 2025
- 1.4.3 On-device / Embedded AI Solutions
- 1.4.4 Hybrid Edge–Cloud AI Platforms
- 1.4.5 AI Plug-ins for Existing Ultrasound Systems
- 1.4.6 Others
- 1.5 Classification of AI Cardiovascular Screening System by AI Functional Depth
- 1.5.1 Overview: Global AI Cardiovascular Screening System Market Size by AI Functional Depth: 2021 Versus 2025 Versus 2032
- 1.5.2 Global AI Cardiovascular Screening System Consumption Value Market Share by AI Functional Depth in 2025
- 1.5.3 Scan Guidance & View Recognition
- 1.5.4 Automated Measurement & Quantification
- 1.5.5 Structural & Functional Abnormality Detection
- 1.5.6 Disease Classification & Risk Stratification
- 1.5.7 Others
- 1.6 Global AI Cardiovascular Screening System Market by Application
- 1.6.1 Overview: Global AI Cardiovascular Screening System Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Medical Institutions
- 1.6.3 Great Health Scene
- 1.7 Global AI Cardiovascular Screening System Market Size & Forecast
- 1.8 Global AI Cardiovascular Screening System Market Size and Forecast by Region
- 1.8.1 Global AI Cardiovascular Screening System Market Size by Region: 2021 VS 2025 VS 2032
- 1.8.2 Global AI Cardiovascular Screening System Market Size by Region, (2021-2032)
- 1.8.3 North America AI Cardiovascular Screening System Market Size and Prospect (2021-2032)
- 1.8.4 Europe AI Cardiovascular Screening System Market Size and Prospect (2021-2032)
- 1.8.5 Asia-Pacific AI Cardiovascular Screening System Market Size and Prospect (2021-2032)
- 1.8.6 South America AI Cardiovascular Screening System Market Size and Prospect (2021-2032)
- 1.8.7 Middle East & Africa AI Cardiovascular Screening System Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 GE Healthcare
- 2.1.1 GE Healthcare Details
- 2.1.2 GE Healthcare Major Business
- 2.1.3 GE Healthcare AI Cardiovascular Screening System Product and Solutions
- 2.1.4 GE Healthcare AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 GE Healthcare Recent Developments and Future Plans
- 2.2 Philips
- 2.2.1 Philips Details
- 2.2.2 Philips Major Business
- 2.2.3 Philips AI Cardiovascular Screening System Product and Solutions
- 2.2.4 Philips AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Philips Recent Developments and Future Plans
- 2.3 UltraSight
- 2.3.1 UltraSight Details
- 2.3.2 UltraSight Major Business
- 2.3.3 UltraSight AI Cardiovascular Screening System Product and Solutions
- 2.3.4 UltraSight AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 UltraSight Recent Developments and Future Plans
- 2.4 Us2.ai
- 2.4.1 Us2.ai Details
- 2.4.2 Us2.ai Major Business
- 2.4.3 Us2.ai AI Cardiovascular Screening System Product and Solutions
- 2.4.4 Us2.ai AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Us2.ai Recent Developments and Future Plans
- 2.5 Ultromics
- 2.5.1 Ultromics Details
- 2.5.2 Ultromics Major Business
- 2.5.3 Ultromics AI Cardiovascular Screening System Product and Solutions
- 2.5.4 Ultromics AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Ultromics Recent Developments and Future Plans
- 2.6 Butterfly Network
- 2.6.1 Butterfly Network Details
- 2.6.2 Butterfly Network Major Business
- 2.6.3 Butterfly Network AI Cardiovascular Screening System Product and Solutions
- 2.6.4 Butterfly Network AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Butterfly Network Recent Developments and Future Plans
- 2.7 Exo Imaging
- 2.7.1 Exo Imaging Details
- 2.7.2 Exo Imaging Major Business
- 2.7.3 Exo Imaging AI Cardiovascular Screening System Product and Solutions
- 2.7.4 Exo Imaging AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Exo Imaging Recent Developments and Future Plans
- 2.8 Canon Medical
- 2.8.1 Canon Medical Details
- 2.8.2 Canon Medical Major Business
- 2.8.3 Canon Medical AI Cardiovascular Screening System Product and Solutions
- 2.8.4 Canon Medical AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Canon Medical Recent Developments and Future Plans
- 2.9 Mindray
- 2.9.1 Mindray Details
- 2.9.2 Mindray Major Business
- 2.9.3 Mindray AI Cardiovascular Screening System Product and Solutions
- 2.9.4 Mindray AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Mindray Recent Developments and Future Plans
- 2.10 Samsung Medison
- 2.10.1 Samsung Medison Details
- 2.10.2 Samsung Medison Major Business
- 2.10.3 Samsung Medison AI Cardiovascular Screening System Product and Solutions
- 2.10.4 Samsung Medison AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Samsung Medison Recent Developments and Future Plans
- 2.11 Clarius Mobile Health
- 2.11.1 Clarius Mobile Health Details
- 2.11.2 Clarius Mobile Health Major Business
- 2.11.3 Clarius Mobile Health AI Cardiovascular Screening System Product and Solutions
- 2.11.4 Clarius Mobile Health AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Clarius Mobile Health Recent Developments and Future Plans
- 2.12 HEBIN
- 2.12.1 HEBIN Details
- 2.12.2 HEBIN Major Business
- 2.12.3 HEBIN AI Cardiovascular Screening System Product and Solutions
- 2.12.4 HEBIN AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 HEBIN Recent Developments and Future Plans
- 2.13 Demetics Medical Technology
- 2.13.1 Demetics Medical Technology Details
- 2.13.2 Demetics Medical Technology Major Business
- 2.13.3 Demetics Medical Technology AI Cardiovascular Screening System Product and Solutions
- 2.13.4 Demetics Medical Technology AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Demetics Medical Technology Recent Developments and Future Plans
- 2.14 Shukun Technology
- 2.14.1 Shukun Technology Details
- 2.14.2 Shukun Technology Major Business
- 2.14.3 Shukun Technology AI Cardiovascular Screening System Product and Solutions
- 2.14.4 Shukun Technology AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Shukun Technology Recent Developments and Future Plans
- 2.15 Shenzhen Keya Medical Technology（）
- 2.15.1 Shenzhen Keya Medical Technology（） Details
- 2.15.2 Shenzhen Keya Medical Technology（） Major Business
- 2.15.3 Shenzhen Keya Medical Technology（） AI Cardiovascular Screening System Product and Solutions
- 2.15.4 Shenzhen Keya Medical Technology（） AI Cardiovascular Screening System Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 Shenzhen Keya Medical Technology（） Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global AI Cardiovascular Screening System Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of AI Cardiovascular Screening System by Company Revenue
- 3.2.2 Top 3 AI Cardiovascular Screening System Players Market Share in 2025
- 3.2.3 Top 6 AI Cardiovascular Screening System Players Market Share in 2025
- 3.3 AI Cardiovascular Screening System Market: Overall Company Footprint Analysis
- 3.3.1 AI Cardiovascular Screening System Market: Region Footprint
- 3.3.2 AI Cardiovascular Screening System Market: Company Product Type Footprint
- 3.3.3 AI Cardiovascular Screening System Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global AI Cardiovascular Screening System Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global AI Cardiovascular Screening System Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global AI Cardiovascular Screening System Consumption Value Market Share by Application (2021-2026)
- 5.2 Global AI Cardiovascular Screening System Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America AI Cardiovascular Screening System Consumption Value by Type (2021-2032)
- 6.2 North America AI Cardiovascular Screening System Market Size by Application (2021-2032)
- 6.3 North America AI Cardiovascular Screening System Market Size by Country
- 6.3.1 North America AI Cardiovascular Screening System Consumption Value by Country (2021-2032)
- 6.3.2 United States AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 6.3.3 Canada AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 6.3.4 Mexico AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe AI Cardiovascular Screening System Consumption Value by Type (2021-2032)
- 7.2 Europe AI Cardiovascular Screening System Consumption Value by Application (2021-2032)
- 7.3 Europe AI Cardiovascular Screening System Market Size by Country
- 7.3.1 Europe AI Cardiovascular Screening System Consumption Value by Country (2021-2032)
- 7.3.2 Germany AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 7.3.3 France AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 7.3.5 Russia AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 7.3.6 Italy AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific AI Cardiovascular Screening System Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific AI Cardiovascular Screening System Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific AI Cardiovascular Screening System Market Size by Region
- 8.3.1 Asia-Pacific AI Cardiovascular Screening System Consumption Value by Region (2021-2032)
- 8.3.2 China AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 8.3.3 Japan AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 8.3.4 South Korea AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 8.3.5 India AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 8.3.7 Australia AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America AI Cardiovascular Screening System Consumption Value by Type (2021-2032)
- 9.2 South America AI Cardiovascular Screening System Consumption Value by Application (2021-2032)
- 9.3 South America AI Cardiovascular Screening System Market Size by Country
- 9.3.1 South America AI Cardiovascular Screening System Consumption Value by Country (2021-2032)
- 9.3.2 Brazil AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 9.3.3 Argentina AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa AI Cardiovascular Screening System Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa AI Cardiovascular Screening System Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa AI Cardiovascular Screening System Market Size by Country
- 10.3.1 Middle East & Africa AI Cardiovascular Screening System Consumption Value by Country (2021-2032)
- 10.3.2 Turkey AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
- 10.3.4 UAE AI Cardiovascular Screening System Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 AI Cardiovascular Screening System Market Drivers
- 11.2 AI Cardiovascular Screening System Market Restraints
- 11.3 AI Cardiovascular Screening System Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 AI Cardiovascular Screening System Industry Chain
- 12.2 AI Cardiovascular Screening System Upstream Analysis
- 12.3 AI Cardiovascular Screening System Midstream Analysis
- 12.4 AI Cardiovascular Screening System Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on AI Cardiovascular Screening System. Industry analysis & Market Report on AI Cardiovascular Screening System is a syndicated market report, published as Global AI Cardiovascular Screening System Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of AI Cardiovascular Screening System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
